BIRC3 overexpression completely abrogated SQLE depletion-enhanced sensitivity of CRC cells to 5-FU treatment (Fig. 3H-I), suggesting that SQLE promoted the resistance of CRC to 5-FU treatment by upregulating BIRC3 expression. The gene discussed is BIRC3; the disease is colorectal carcinoma.